| Literature DB >> 34067333 |
Mariana N Oliveira1, Oriana C Gonçalves1, Samir M Ahmad1,2,3, Jaderson K Schneider4, Laiza C Krause4, Nuno R Neng1,5, Elina B Caramão4,6, José M F Nogueira1,5.
Abstract
This work entailed the development, optimization, validation, and application of a novel analytical approach, using the bar adsorptive microextraction technique (BAμE), for the determination of the six most common tricyclic antidepressants (TCAs; amitriptyline, mianserin, trimipramine, imipramine, mirtazapine and dosulepin) in urine matrices. To achieve this goal, we employed, for the first time, new generation microextraction devices coated with convenient sorbent phases, polymers and novel activated carbons prepared from biomaterial waste, in combination with large-volume-injection gas chromatography-mass spectrometry operating in selected-ion monitoring mode (LVI-GC-MS(SIM)). Preliminary assays on sorbent coatings, showed that the polymeric phases present a much more effective performance, as the tested biosorbents exhibited low efficiency for application in microextraction techniques. By using BAμE coated with C18 polymer, under optimized experimental conditions, the detection limits achieved for the six TCAs ranged from 0.2 to 1.6 μg L-1 and, weighted linear regressions resulted in remarkable linearity (r2 > 0.9960) between 10.0 and 1000.0 μg L-1. The developed analytical methodology (BAμE(C18)/LVI-GC-MS(SIM)) provided suitable matrix effects (90.2-112.9%, RSD ≤ 13.9%), high recovery yields (92.3-111.5%, RSD ≤ 12.3%) and a remarkable overall process efficiency (ranging from 84.9% to 124.3%, RSD ≤ 13.9%). The developed and validated methodology was successfully applied for screening the six TCAs in real urine matrices. The proposed analytical methodology proved to be an eco-user-friendly approach to monitor trace levels of TCAs in complex urine matrices and an outstanding analytical alternative in comparison with other microextraction-based techniques.Entities:
Keywords: GC-MS; bar adsorptive microextraction (BAμE); biomaterials waste; flotation sampling technology; novel sorbent phases; tricyclic antidepressants; urine samples
Mesh:
Substances:
Year: 2021 PMID: 34067333 PMCID: PMC8196885 DOI: 10.3390/molecules26113101
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Chemical structures of the six TCAs studied in the present work.
Target ions (base peaks in bold) and quantifier ions for each TCA studied by LVI-GC-MS(SIM), under optimized instrumental conditions.
| TCAs | Ions | Retention Time |
|---|---|---|
|
| 12.91 | |
|
| 13.13 | |
|
| 13.22 | |
|
| 58/ | 13.28 |
|
| 13.77 | |
|
| 15.96 |
Figure 2Remaining TCAs present in the aqueous matrix after the microextraction stage using the four different ACs prepared from biomaterials waste.
Figure 3Effect of MeOH (a) and MeOH:ACN mix (b) stripping solvents on the back-extraction of the six TCAs from the different polymer phases by BAµE-µLD/LVI-GC-MS(SIM). The error bars represent the standard deviation of three replicates.
Figure 4Effect of matrix pH using SX (a) and C18 (b) sorbent phases, percentage of NaCl (c) and equilibrium time (d) on the microextraction efficiency of six TCAs in aqueous media by BAµE-µLD/LVI-GC-MS(SIM). The error bars represent the standard deviation of three replicates.
Figure 5Effect of substrate type on the microextraction efficiency for the six TCAs in aqueous media by BAµE(C18)-µLD/LVI-GC-MS(SIM). The error bars represent the standard deviation of three replicates.
LODs, LLOQs, calibration equations and r2 achieved for the six TCAs through BAμE(C18)-μLD/LVI-GC-MS(SIM) methodology, under optimized experimental conditions.
| TCAs | LODs | LLOQs | Calibration Equations |
|
|---|---|---|---|---|
|
| 0.20 | 10.00 | y = 34.4780 x − 0.0174 | 0.9974 |
|
| y = 7.3701 x − 0.0026 | 0.9974 | ||
|
| y = 13.0250 x − 0.0033 | 0.9988 | ||
|
| y = 3.5938 x − 0.0027 | 0.9960 | ||
|
| 0.39 | y = 11.2264 x − 0.0026 | 0.9982 | |
|
| 1.56 | y = 29.1992 x − 0.0094 | 0.9978 |
Inter and intraday accuracy and precision levels obtained for the six TCAs at four different concentrations by BAμE(C18)-μLD/LVI-GC-MS(SIM) methodology, under optimized experimental conditions.
| TCAs | Spiking Level | Intraday | Interday | ||||
|---|---|---|---|---|---|---|---|
| Accuracy (%) ± Precision (%) | Accuracy (%) ± Precision (%) | ||||||
|
| 10.0 | 5.1 | ± | 8.2 | 20.0 | ± | 15.0 |
| 50.0 | −5.5 | ± | 4.6 | −5.0 | ± | 8.9 | |
| 500.0 | 1.7 | ± | 4.8 | 2.9 | ± | 12.2 | |
| 1000.0 | 4.8 | ± | 8.8 | −4.4 | ± | 11.8 | |
|
| 10.0 | −6.6 | ± | 4.3 | −2.8 | ± | 16.7 |
| 50.0 | −0.5 | ± | 11.1 | 0.1 | ± | 13.2 | |
| 500.0 | 4.8 | ± | 8.6 | 1.9 | ± | 11.8 | |
| 1000.0 | −0.1 | ± | 8.9 | 2.5 | ± | 13.2 | |
|
| 10.0 | 0.9 | ± | 6.8 | 13.1 | ± | 18.1 |
| 50.0 | −1.7 | ± | 6.1 | 11.0 | ± | 13.8 | |
| 500.0 | 5.7 | ± | 4.8 | 13.0 | ± | 9.2 | |
| 1000.0 | −4.1 | ± | 13.7 | 5.8 | ± | 11.7 | |
|
| 10.0 | −8.4 | ± | 9.0 | 14.8 | ± | 17.6 |
| 50.0 | 6.7 | ± | 12.8 | 2.4 | ± | 14.5 | |
| 500.0 | −1.2 | ± | 6.3 | 14.2 | ± | 14.9 | |
| 1000.0 | −0.5 | ± | 11.2 | −4.3 | ± | 10.1 | |
|
| 10.0 | 1.3 | ± | 15.8 | 15.9 | ± | 19.9 |
| 50.0 | 13.3 | ± | 0.9 | 14.5 | ± | 2.1 | |
| 500.0 | 6.5 | ± | 6.0 | 13.0 | ± | 12.1 | |
| 1000.0 | −0.7 | ± | 7.3 | 11.1 | ± | 13.8 | |
|
| 10.0 | 8.1 | ± | 0.4 | 14.1 | ± | 9.4 |
| 50.0 | 14.2 | ± | 2.5 | 1.0 | ± | 13.5 | |
| 500.0 | −8.2 | ± | 10.3 | −4.5 | ± | 14.5 | |
| 1000.0 | −12.0 | ± | 7.2 | −8.2 | ± | 10.1 | |
Matrix effects, recovery yields and process efficiency obtained for the six TCAs at two different concentrations by BAμE(C18)-μLD/LVI-GC-MS(SIM) methodology, under optimized experimental conditions.
| TCAs | Spiking Level (μg L−1) | Matrix Effects | Recovery Yields | Process Efficiency | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| 25.0 | 90.2 | ± | 6.6 | 95.3 | ± | 9.6 | 86.0 | ± | 7.5 |
| 750.0 | 93.7 | ± | 12.5 | 107.9 | ± | 6.9 | 101.1 | ± | 12.9 | |
|
| 25.0 | 100.1 | ± | 9.8 | 95.3 | ± | 7.2 | 95.4 | ± | 8.6 |
| 750.0 | 111.5 | ± | 11.2 | 111.5 | ± | 7.7 | 124.3 | ± | 11.7 | |
|
| 25.0 | 102.1 | ± | 8.4 | 103.3 | ± | 9.3 | 105.5 | ± | 12.0 |
| 750.0 | 99.3 | ± | 8.2 | 109.0 | ± | 5.0 | 108.2 | ± | 7.9 | |
|
| 25.0 | 91.9 | ± | 4.1 | 92.3 | ± | 11.1 | 84.9 | ± | 10.4 |
| 750.0 | 109.3 | ± | 13.9 | 106.5 | ± | 10.0 | 116.5 | ± | 12.6 | |
|
| 25.0 | 95.6 | ± | 10.9 | 108.5 | ± | 12.3 | 103.6 | ± | 12.0 |
| 750.0 | 112.9 | ± | 14.4 | 99.0 | ± | 9.9 | 111.7 | ± | 13.9 | |
|
| 25.0 | 91.3 | ± | 4.4 | 99.6 | ± | 8.9 | 90.9 | ± | 8.4 |
| 750.0 | 99.4 | ± | 11.6 | 103.7 | ± | 7.5 | 103.1 | ± | 13.9 | |
Figure 6Chromatograms obtained from urine samples spiked at the 100.0 μg L−1 for six TCAs (a) and a positive anonymous donor without spiking (b) analyzed through BAµE(C18)-µLD/LVI-GC-MS(SIM) methodology, under optimized experimental conditions.
Comparison between the present study and others analytical approaches already reported in the literature for each six TCAs determination in urine and water matrices.
| Analytical Method | TCAs | Recovery Yields (%) | RSD | LOD | LOQ (µg L−1) | Linear Range |
| Ref. |
|---|---|---|---|---|---|---|---|---|
|
| AMT, MIA, TRI, IMP, MIR, DOT | ~100.0 | <9.6 | 0.20 | 10.0 | 10.0–1000.0 | 0.9974 | This study |
|
| AMT, IMP | 98.5–99.5 | [ | |||||
|
| AMT, MIA, TRI, MIR, DOT | 64.4–99.8 | 6.0–20.6 | 1.0–2.5 | - | 1.0–320.0 | 0.9963–0.9996 | [ |
|
| AMT, IMP | 69.0–84.0 | 3.0–4.0 | 0.2–0.3 | 0.7–1.1 | 0.7–1000.0 | 0.9960–0.9970 | [ |
|
| TRI | 112.0 | 6.1 | 0.6 | - | 2.0–100.0 | 0.9946 | [ |
|
| AMT, IMP, | - | 6.8 | - | - | - | [ | |
|
| AMT, IMP | 88.2–103.6 | 7.4–7.9 | 0.5 | 2.0 | 2.0–100.0 | 0.9990 | [ |
DLLME: Dispersive liquid-liquid microextraction GC: Gas chromatography; HF-LPME: Hollow fiber-liquid phase microextraction; HPLC: High performance liquid chromatography; MS: Mass spectrometry; MSPE: Magnetic solid-phase extraction; RR: Relative recovery; SI-HLLE-DSPE-DLLME-SFO: Salt induced-homogenous liquid-liquid extraction, dispersive solid phase extraction, and dispersive liquid–liquid microextraction based on the solidification of floating organic droplet; SPE: Solid-phase extraction; Ultraviolet.